Results 111 to 120 of about 12,272 (191)

Comparative Efficacy of Statins Versus PCSK9 Inhibitors in Coronary Heart Disease Treatment. [PDF]

J Am Heart Assoc
Yu L, Xiang B, Ren Y, Li Y, Xie J, Zhou X.   +5 more
europepmc   +1 more source

PCSK9 inhibitors conquer primary prevention: the VESALIUS-CV study. [PDF]

Eur Heart J Suppl
Gatto L, Di Bitonto MP, Scalia L, Biccirè FG, Prati F.   +4 more
europepmc   +1 more source

PCSK9 Inhibitors and Bipolar Disorder: A Drug Target Mendelian Randomization Study. [PDF]

Clin Neuropharmacol
Li J, Yao PS.
europepmc   +1 more source

Therapeutic Potential of PCSK9 Inhibitors in Regulating Neuroinflammation in Acute Ischemic Stroke. [PDF]

CNS Drugs
Pu L, Liu J, Kong S, Joyama Y, Gong X, Ji X, Dong H.   +6 more
europepmc   +1 more source

Synthesis of a PCSK9 Inhibitor [PDF]

Synfacts, 2018
openaire   +1 more source

Knowledge, Attitudes, and Practices Regarding PCSK9 Inhibitors Among Healthcare Professionals: Exploring Behavioral Pathways and the Intermediary Role of Attitude. [PDF]

J Multidiscip Healthc
Zhao C, Wang N, Shen D, Zhu L, Chen G.
europepmc   +1 more source

Access to PCSK9 Inhibitors

Reviews in Cardiovascular Medicine, 2018
Jennifer G. Robinson, Norman E. Lepor, Seth J. Baum   +2 more
openaire   +1 more source

Naturally Occurring PCSK9 Inhibitors: An Updated Review. [PDF]

Molecules
Huh J, Kim H.
europepmc   +1 more source

PCSK9 inhibitors: a promising lipid-lowering strategy for kidney transplant recipients. [PDF]

Ren Fail
Luo B, Guo L, Di W.
europepmc   +1 more source

Outcomes of PCSK9 Inhibitors

JACC: Advances, 2023
openaire   +1 more source